Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Serratus plane block versus capsaicin versus botulinum toxin A for post-mastectomy neuropathic pain
2024-517420-20-00Phase 2Completed
- Sponsor
- Centre Oscar Lambret
- Start
- Jun 2025
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of capsaicin, botulinum toxin type A and ropivacaine + clonidine in Post-mastectomy pain syndrome (PMPS) and Neuralgia (3 arms), sponsored by Centre Oscar Lambret. Primary endpoint: Pain intensity at 8 weeks. Started Jun 2025; status: completed.
02
Drugs
capsaicinbotulinum toxin type Aropivacaine + clonidine
03
Conditions
Post-mastectomy pain syndrome (PMPS)Neuralgia
Beyond the preview
Go deeper on 2024-517420-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517420-20-00.